Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

AMSTERDAM, The Netherlands, September 18 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a license from Amgen to use their GDNF gene for the development of a gene therapy treatment for Parkinson's disease. The combination of this gene with AMT's proprietary adeno-associated virus (AAV) gene therapy platform could potentially allow the development of an effective, long-term treatment for this progressive and crippling disease.

SUSSEX, England, September 18 /PRNewswire/ -- Leading Sussex based law firm Rix & Kay Solicitors LLP, is delighted to announce that it is supporting a major scientific expedition to the North Pole to capture vitally needed data for scientists studying the impact of global warming on the Arctic ice cap.

Expedition leader, explorer and environmentalist Pen Hadow said that the aim of the Arctic Survey is to measure the exact thickness of the permanent Arctic ice and so determine more accurately the rate at which it is melting.

SEOUL, South Korea, September 18 /PRNewswire/ --

-- The largest event for small and medium business in Korea -- 500 small and medium business in sectors such as biotechnology, electronics, information technology and more will exhibit products at Inno-Tech Show 2008 -- October 23 - 26, 2008, COEX, Seoul, KOREA

A fair featuring innovative technologies developed by Korean small and medium business will be held in Seoul.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080917/HKW004 )

Taking place from October the 23rd thru the 26th, Inno-Tech 2008 will be sponsored by the Small and Medium Business Administration and organized by the Innobiz Association. It will be held at the COEX Pacific Hall in Samseong-dong, Seoul.

LONDON, September 18 /PRNewswire/ --

LONDON, September 18 /PRNewswire/ --

- Call for Massive Investment in Health Visiting to Meet Government Goals

A quarter of health visitors in England fear that 'another Victoria Climbie' could happen in their NHS trust, new research from Unite, the country's largest trade union, revealed today (Thursday, 18 September).

The survey by Unite/Community Practitioners' and Health Visitors' Association of 829 health visitors in England revealed 25% thought the chances of a repetition of the fate of the eight-year old girl tortured to death by her great-aunt and her boyfriend happening in their NHS trust was 'very likely' or 'somewhat likely'.

WASHINGTON, September 17 /PRNewswire/ --

- With the Help of New Members

SAN FRANCISCO, September 17 /PRNewswire/ --

- DDB and Tribal DDB to Team Up as AOR for McAfee's Global Brand Advertising Programs

SAN FRANCISCO, September 17 /PRNewswire/ --

Tribal DDB Worldwide announced today that it has been selected, along with partners DDB Worldwide and OMD, by McAfee, Inc., to lead its global advertising account. Charged with the integrated marketing communications strategy for the McAfee(R) brand, Tribal DDB and partners will build a global brand campaign that will encompass strategic planning, creative development, and media buying and planning.